LITE's Laser Growth Accelerates: Can It Challenge AVGO & AAOI?

Lumentum's pump-laser shipments rose more than 80% year over year in fiscal Q4 2026, and the company expects shipments to increase roughly fourfold over the next several quarters as hyperscaler AI infrastructure drives optical-connectivity demand. Management expects more than 50% year-over-year EML unit growth in fiscal Q3 2027, while ultra-high-power laser revenue could approach $50 million by the end of 2026 and reach a first triple-digit quarterly level in fiscal Q3 2027. The bullish outlook is partly offset by a demanding 41.24x forward P/E versus the sector's 20.73x and expanding competition from Broadcom and Applied Optoelectronics; consensus EPS of $4.22 has increased $0.66 in 30 days, implying 283.64% year-over-year growth.

Analysis

LITE's bottlenecked laser supply is more important than the reported demand growth: constrained qualified indium-phosphide capacity makes revenue conversion and gross-margin realization dependent on yield ramps, not end-market demand. Long-term customer commitments reduce utilization risk, but likely embed pricing/volume obligations; the key earnings sensitivity over the next 1-3 quarters is whether incremental capacity lifts shipments without a mix-driven gross-margin reset. The market is already capitalizing a near-flawless ramp, leaving little tolerance for a single qualification delay or muted forward capacity commentary.

AVGO is the structural winner if optics migrate from pluggables toward CPO/NPO because it can bundle switching silicon, DSPs, SerDes and optical components into a validated system. That architecture shifts value from discrete laser vendors toward the platform owner, even if total laser dollars rise. LITE can still win in external-light-source deployments, but CPO adoption over 6-18 months creates customer-concentration and bargaining-power risk rather than a simple incremental TAM benefit.

AAOI is the higher-beta competitive disruptor: aggressive internal capacity additions can turn today's supply scarcity into pricing pressure once qualification cycles catch up. The contrarian view is that CPO deployment remains slower than investor expectations because thermal management, serviceability and hyperscaler reliability validation favor mature pluggable 800G/1.6T architectures; this supports LITE's nearer-term EML ramp but delays the highest-power laser upside. Watch LITE's gross margin, backlog conversion, customer prepayments and capex-to-revenue efficiency rather than shipment targets alone.

Key Decisions for Investors

• Do not add outright LITE after the rerating; maintain only a tactical position into the next earnings report if channel checks confirm qualified InP capacity and stable pricing. Exit or hedge on gross-margin guide-down, capex escalation without customer funding, or any reduction in 200G EML mix targets; at the current valuation, a 10-15% earnings reset could produce materially larger multiple compression.
• Prefer a 6-12 month long AVGO / short LITE pair, sized beta-neutral. The trade captures AVGO's system-level CPO optionality while hedging broad AI-optics demand; close if LITE demonstrates sustained margin expansion alongside capacity additions or if AVGO's networking growth decelerates materially.
• Keep AAOI on a catalyst watch rather than chase: initiate only after evidence of customer qualification and utilization at new laser capacity, since announced fab capacity is not equivalent to revenue. A credible ramp would pressure LITE's medium-term premium pricing; failure to qualify on schedule is the falsifier.
• For LITE holders, use post-earnings volatility to buy downside protection 3-6 months out rather than upside calls. The asymmetry is unfavorable while expectations embed high shipment growth, whereas a clean beat may be constrained by already elevated valuation.